Cancer Misdiagnosis Claims in Scotland Explained
A cancer diagnosis is one of the most frightening things a person can face. But there is a category of experience that is in some ways even more devastating than receiving a cancer diagnosis — discovering that you had cancer, that it was there to be found, and that it was missed. That a GP dismissed symptoms that should have prompted urgent referral. That a radiologist misread a scan. That a pathologist reported a biopsy as benign when it was malignant. That a screening programme failed to identify an abnormality that was visible in retrospect. That months or years passed while the cancer grew, spread, and became harder or impossible to treat — time during which the right diagnosis would have changed everything.
Cancer misdiagnosis is one of the most significant categories of clinical negligence claim in Scotland. It encompasses a range of different types of failure — delayed diagnosis, failure to diagnose, misinterpretation of test results, failure to refer for investigation, failure to follow up, and errors in the reporting of pathology or imaging — each of which can have profound consequences for the patient's prognosis, treatment options, and survival. Understanding how these claims work in Scotland, what the legal test requires, what evidence is needed, what the specific challenges of this category of litigation are, and what compensation is available is essential for any patient or family affected by a cancer misdiagnosis in Scotland.
The Types of Cancer Misdiagnosis
Cancer misdiagnosis claims in Scotland arise from a wide range of different clinical failures, and the specific nature of the failure shapes both the legal analysis and the medical evidence required.
The most common category is delayed diagnosis — where the cancer was eventually diagnosed but later than it should have been. A patient who presented to their GP with symptoms consistent with bowel cancer and was reassured without investigation, only for the cancer to be diagnosed eighteen months later at a more advanced stage, has suffered a delayed diagnosis. The harm in a delayed diagnosis case is typically the difference between the prognosis at the time of the negligent failure and the prognosis at the time of actual diagnosis — the extent to which the delay allowed the cancer to progress to a more advanced stage, reduced the treatment options available, worsened the outcome, or reduced the patient's life expectancy.
Failure to diagnose is a more serious category — where the cancer was never identified despite opportunities to find it, and the patient either died without a correct diagnosis or received a diagnosis at a point when the cancer was untreatable. This may arise from a complete failure to investigate symptoms, from a false negative result that was accepted without appropriate follow-up, or from a systematic failure in a screening programme.
Misinterpretation of test results is a category involving errors by radiologists, pathologists, or other diagnostic specialists who reviewed tests but reached incorrect conclusions. A radiologist who reports a chest X-ray as normal when a lesion is visible on the image, a pathologist who reports a biopsy as benign when the cells show malignant change, or a cytologist who misreads a cervical smear — each of these represents a diagnostic error that may give rise to a clinical negligence claim.
Failure to refer is a category that arises most commonly in primary care — where a GP sees a patient with symptoms that should have prompted an urgent or routine referral for specialist investigation under the relevant clinical guidelines, but fails to refer or delays referring, with the result that the diagnosis is made later than it should have been. NICE guidelines and the equivalent Scottish guidance from Healthcare Improvement Scotland set out specific criteria for urgent and routine referral that GPs are expected to follow, and a failure to meet those criteria where the clinical presentation justified referral is potentially negligent.
Failure to follow up is a category involving situations where abnormal results were identified but not acted upon — where a GP received a letter from a specialist suggesting further investigation was needed but took no action, or where a hospital department identified an incidental finding on a scan that required follow-up but failed to arrange it. These failures in the systems of communication and follow-up within the NHS can result in significant delays that worsen the patient's prognosis.
Errors in cancer screening — cervical screening, bowel cancer screening, breast screening — form a distinct category where the national screening programme has failed to identify a cancer that should have been detected. Screening errors may involve individual reporting failures — a cytologist or radiologist who misreads a screening sample — or systemic failures in the administration of the screening programme.
The Legal Framework: Hunter v Hanley and Cancer Misdiagnosis
As with all clinical negligence claims in Scotland, the legal test for establishing liability in a cancer misdiagnosis case is the Hunter v Hanley standard. The claimant must prove that there is a usual and normal practice in the relevant field, that the defender departed from that practice, and that the departure was one that no ordinarily skilled practitioner exercising ordinary care would have made.
In the cancer misdiagnosis context, the relevant field of practice and the applicable standard of care depends on the specific type of failure alleged. For a GP failure to refer, the relevant standard is the approach of a reasonably competent general practitioner to the presenting symptoms — would a GP of ordinary skill, exercising ordinary care, have referred this patient for investigation given the symptoms described? For a radiological error, the relevant standard is that of a reasonably competent radiologist — would a radiologist of ordinary skill, examining this image with ordinary care, have identified the abnormality? For a pathological error, the standard is that of a reasonably competent histopathologist.
The published clinical guidelines — NICE guidelines, Scottish Intercollegiate Guidelines Network guidelines, the relevant Royal College standards — are important reference points in establishing the usual and normal practice. A GP who failed to refer a patient meeting the criteria for urgent referral in the relevant NICE guideline has strong evidence of a departure from normal practice against them. A radiologist whose report omits a lesion that subsequent expert review identifies as clearly visible on the image has similar evidence of departure. The guidelines do not replace the expert evidence — the Hunter v Hanley test still requires expert opinion on whether the departure was one that no ordinarily skilled practitioner would have made — but they provide an important framework within which the expert analysis is conducted.
Causation: The Central Challenge
Causation is frequently the most contested and most technically demanding aspect of a cancer misdiagnosis claim in Scotland. Even where breach of duty is clearly established — where the failure to diagnose or refer is not seriously in dispute — the question of what difference that failure made to the patient's outcome is often complex and fiercely contested.
The fundamental causation question in a delayed diagnosis case is whether the delay in diagnosis changed the patient's prognosis. Where the cancer was at an early and curable stage at the time of the negligent failure, and has progressed to an advanced and incurable stage by the time of the actual diagnosis, the causal link between the delay and the worsened outcome is relatively clear — the delay allowed the cancer to progress from a curable to an incurable condition, and the patient has lost the chance of cure. In these cases, establishing causation is more straightforward, and the compensation reflects the catastrophic consequences of the loss of a cure.
Where the cancer was already at an advanced stage at the time of the negligent failure — where even a timely diagnosis would not have produced a cure — the causation analysis is more nuanced. In these cases, the question is not whether the delay caused the patient to die of cancer — they would have died of cancer in any event — but whether the delay caused them to die sooner, to suffer more, to have fewer treatment options, or to have a diminished quality of life during the period of survival. These are questions that require careful statistical and clinical analysis of the available evidence on survival rates and treatment outcomes at different stages of the specific cancer type.
The loss of chance doctrine is particularly relevant in cancer misdiagnosis cases. In some situations, the claimant cannot establish on the balance of probabilities that a timely diagnosis would have produced a better outcome — the cancer may have been at a stage where even timely diagnosis would have offered only a fifty percent or lower chance of cure. In English law, the loss of chance doctrine in clinical negligence was significantly restricted by the House of Lords in Gregg v Scott. The position in Scots law on loss of chance in clinical negligence is a nuanced and developing area, and the interaction between the balance of probabilities standard and the assessment of lost chances requires careful expert and legal analysis in individual cases.
Where the lost chance can be expressed as a probability — the patient had a sixty percent chance of cure with timely diagnosis, and a twenty percent chance with the delayed diagnosis — the compensation may be assessed to reflect the lost forty percent chance of cure rather than the full value of a certain loss of life. The specific approach taken depends on the facts of the case and the expert evidence available.
The Medical Expert Evidence
Cancer misdiagnosis claims require expert evidence from a range of medical specialties, the specific combination of which depends on the nature of the failure and the type of cancer involved.
For a GP failure to refer, the primary expert is a general practitioner with specific experience in the recognition and referral of the relevant cancer type. They will give evidence on what the presenting symptoms indicated and what a GP of ordinary skill should have done in response, having regard to the applicable guidelines and the clinical picture documented in the records.
For a radiological failure, the primary expert is a consultant radiologist with experience in reporting the relevant imaging modality — chest X-ray, CT scan, MRI scan, mammogram, or whatever imaging is in issue. They will review the original images and report, give an opinion on what the images showed, and address whether a competent radiologist exercising ordinary care should have identified the relevant abnormality.
For a pathological failure, the primary expert is a consultant histopathologist or cytopathologist with experience in the relevant tissue type. They will review the original slides — the microscopic preparations from the biopsy or cytology sample — and give an opinion on whether the reporting of those slides as benign was a departure from normal practice that no ordinarily skilled pathologist would have made.
For the oncological consequences — the impact of the delay on the patient's prognosis and treatment — the primary expert is a consultant oncologist specialising in the relevant cancer type. They will give evidence on the natural history of the cancer, the stage at which it was and should have been diagnosed, the treatment options that would have been available with timely diagnosis, and the difference in prognosis between earlier and later diagnosis.
In cases where the patient has died, a further expert may be required to address life expectancy — specifically the statistical evidence on survival rates at different stages of the relevant cancer type, which provides the evidential basis for calculating the loss of life expectancy and the financial losses flowing from it.
Specific Cancer Types and Their Particular Considerations
Different types of cancer present different clinical and legal considerations in the misdiagnosis context, and a brief overview of some of the most common categories of claim illustrates the range of issues that arise.
Bowel cancer misdiagnosis claims are among the most frequently litigated cancer negligence cases in Scotland. The symptoms of bowel cancer — change in bowel habit, rectal bleeding, abdominal pain, unexplained weight loss — can be attributed by a GP to benign conditions such as haemorrhoids or irritable bowel syndrome, and the failure to refer despite persistent or concerning symptoms is a common basis for a claim. The NICE and Scottish guidelines on urgent referral for suspected colorectal cancer provide a clear framework for assessing whether a GP's failure to refer was negligent. The consequences of delayed diagnosis can be severe — bowel cancer that is curable at stage one or two becomes incurable at stage four, and the difference in prognosis between the stages is stark.
Breast cancer misdiagnosis claims arise from failures at GP level, from errors in mammographic reporting within the breast screening programme, and from failures by surgeons or radiologists to correctly investigate a breast lump or abnormality. The breast screening programme in Scotland involves mammographic screening of women between fifty and seventy years old, and errors in the reporting of screening mammograms are a recognised category of clinical negligence claim. A missed breast cancer on a screening mammogram that is identified at the next screening round two or three years later, at a more advanced stage, is a classic delayed diagnosis scenario.
Lung cancer misdiagnosis claims arise from failures to investigate respiratory symptoms — persistent cough, haemoptysis, unexplained weight loss, chest pain — that should have prompted urgent referral or chest imaging. Lung cancer has a poor prognosis at advanced stages and a significantly better prognosis at early stages, making the difference between a timely and a delayed diagnosis potentially very significant. The attribution of respiratory symptoms to smoking or chronic obstructive pulmonary disease without appropriate investigation is a common basis for a negligence claim.
Cervical cancer misdiagnosis claims arise from errors in cervical cytology — the reporting of cervical smear samples in the screening programme — and from failures to appropriately investigate abnormal smear results or symptoms. Scotland has its own cervical screening programme — the Scottish Cervical Call Recall Service — and errors within that programme may give rise to claims.
Melanoma and skin cancer misdiagnosis claims arise from failures by GPs to recognise the features of malignant melanoma or other skin cancers and refer appropriately. The ABCDE criteria for melanoma recognition — asymmetry, border, colour, diameter, evolution — provide a framework for assessment, and a failure to refer a lesion with concerning features is potentially negligent.
The Pre-Action Process and the Central Legal Office
Cancer misdiagnosis claims against NHS Scotland are handled by the Central Legal Office in the same way as all other clinical negligence claims. The pre-action process involves sending a detailed letter of claim to the CLO setting out the basis of the alleged negligence, the harm caused, and the losses flowing from it. The CLO investigates the claim through its own expert evidence and responds with the health board's position on liability.
In cancer misdiagnosis cases, the CLO's investigation typically involves instructing an independent expert in the relevant specialty — a GP expert for a failure to refer claim, a radiologist for an imaging error claim, a pathologist for a reporting error claim — to review the records and provide an opinion on whether the care fell below the Hunter v Hanley standard. The CLO will also typically instruct an oncological expert to address the causation question — whether and to what extent the delay in diagnosis affected the patient's prognosis.
Where the CLO's expert evidence supports the claimant's case, the CLO may admit liability at the pre-action stage. In cancer misdiagnosis cases with clear breach of duty and clear causation, early admissions are not uncommon, and the litigation then focuses on the assessment of the damages. Where the CLO's expert evidence does not support the claim, the denial of liability will be maintained and court proceedings will be necessary to resolve the dispute.
The emotional dimension of dealing with the CLO on behalf of a cancer patient or their bereaved family requires sensitivity and care from the claimant's solicitor. The pre-action process in a fatal cancer misdiagnosis case — where the family is simultaneously grieving and pursuing a legal claim — is one of the most demanding aspects of clinical negligence practice, and the quality of the solicitor's engagement with the family is as important as the quality of their legal work.
Compensation in Cancer Misdiagnosis Cases
Compensation in a successful cancer misdiagnosis claim in Scotland covers the full range of losses flowing from the negligent failure, calculated by reference to the difference between the patient's actual position as a result of the delayed or missed diagnosis and the position they would have been in had the diagnosis been made at the appropriate time.
Where the patient has survived and the delayed diagnosis has worsened their prognosis — where they now face a shorter life expectancy or a greater risk of recurrence than they would have faced with a timely diagnosis — the compensation includes solatium for the additional pain, suffering, and loss of amenity caused by the more advanced treatment required, for the psychological impact of a worsened prognosis, and for the reduction in life expectancy and quality of life.
Where the patient has died and the negligent delay caused or contributed to their death, the claim includes the estate's claim for the pain and suffering of the deceased during the period between the negligent failure and the death — the solatium for the additional suffering caused by the advanced presentation and more aggressive treatment — and the family's claim under the Damages (Scotland) Act 2011 for loss of support and loss of society.
The financial losses in a cancer misdiagnosis case depend on the specific circumstances. Where the patient was working at the time of the negligent failure and the advanced diagnosis has caused them to leave work earlier than they would have done with a timely diagnosis, past and future wage loss is recoverable. Where the patient has died and was the household's primary earner, the loss of support claim under the 2011 Act reflects the financial dependency of the surviving family. Care costs, medical treatment costs, and all other heads of special damages are recoverable in the usual way.
In cases where the patient is still alive with a reduced life expectancy, the compensation must grapple with the difficult question of future losses in a situation where the future is uncertain. The medical expert evidence on life expectancy, and the actuarial application of the Ogden Tables to that evidence, must reflect the specific prognosis in the individual case. Where the prognosis is very poor, the future loss calculation may be based on a short projected survival period that limits the multipliers for future losses. Where the prognosis allows for a longer but reduced life expectancy, the calculations are more involved and require careful expert input.
Practical Steps for Affected Patients and Families
For any patient or family in Scotland who believes that a cancer diagnosis was delayed or missed due to a failure in clinical care, the practical steps follow the same pattern as any clinical negligence claim — but with particular urgency given the nature of the condition.
Seeking specialist legal advice from a solicitor with specific experience in cancer misdiagnosis claims in Scotland is the essential first step. The complexity of the causation analysis, the range of expert disciplines involved, the involvement of the Central Legal Office, and the sensitivity of the subject matter all make specialist expertise essential. A solicitor who handles cancer misdiagnosis claims regularly will know which experts to instruct, how to frame the causation analysis in the specific type of cancer involved, and how to pursue the claim with both legal rigour and human sensitivity.
Obtaining the medical records promptly is the second essential step. The records — GP records, hospital records, imaging, pathology reports, screening records — are the foundation of the entire claim and should be requested as early as possible. In fatal cases, the executor of the estate has the right to access the deceased's records under the Access to Health Records Act 1990, and those records should be obtained without delay.
The three year limitation period applies — running from the date the patient knew or ought to have known that their cancer had been misdiagnosed and that this was attributable to a failure in their care. In cases involving a living patient, this is typically the date of the correct diagnosis or the date the patient became aware that the earlier presentation had been mishandled. In fatal cases, the three years run from the date of death. Legal advice on the limitation position should be sought as a matter of urgency in any case where the timing is uncertain.
The Bottom Line
Cancer misdiagnosis claims in Scotland represent some of the most serious and most consequential clinical negligence cases in the system. They involve a failure at one of the most critical moments in a patient's medical history — the moment when the identification of cancer would have made the greatest difference — and the consequences of that failure can include the loss of a cure, the loss of years of life, and the loss of the full enjoyment of life that the patient would have had with a timely diagnosis.
The legal system of Scotland provides a rigorous and comprehensive framework for these claims — the Hunter v Hanley test, the Court of Session and the All-Scotland Sheriff Personal Injury Court, the CLO as the NHS's defender, and the full range of compensation available for the losses suffered. Navigating that framework requires specialist expertise, meticulous preparation, and the human sensitivity that these deeply personal and often devastating cases demand. For patients and families affected by cancer misdiagnosis in Scotland, understanding the framework is the first step toward accessing the justice and the compensation they are entitled to.